OYSTER POINT PHARMA I, LLC 4
4 · Oyster Point Pharma, Inc. · Filed Nov 5, 2019
Insider Transaction Report
Form 4
OYSTER POINT PHARMA I, LLC
10% Owner
Transactions
- Conversion
Common Stock, par value $0.001 per share
2019-11-04+955,392→ 955,392 total - Conversion
Series B Convertible Preferred Stock
2019-11-04−955,392→ 0 total→ Common Stock, par value $0.001 per share (955,392 underlying)
Footnotes (2)
- [F1]These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date.
- [F2]Consists of 955,392 shares of common stock beneficially owned by Oyster Point Pharma I, LLC. William J. Link, as a managing partner of Oyster Point Pharma I, L.L.C., may be deemed to share voting and dispositive power over the shares held by Oyster Point Pharma I, LLC.